| NCT ID | NCT07325162 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cassini Technologies |
| Condition | Cataract and IOL Surgery |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-11-07 |
| Primary Completion | 2026-02-28 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2025-11-07 with a primary completion date of 2026-02-28.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The Helioscope (Cassini Technologies B.V.) is a novel device under development that aims at combining LED-based corneal topography and SS-OCT to provide accurate and fast measurements of both the corneal shape and the ocular biometry. To that end, the hardware and software of the Cassini color-LED topographer (Cassini Technologies B.V.) is combined with a novel SS-OCT device. While the new Helioscope can largely be evaluated using data acquired with healthy eyes, one of its main use-cases is providing input for IOL power formulae for cataract surgery. Thus, it is essential that the device can perform measurements in eyes with (dense) cataract. As cataract changes the optical properties of the crystalline lens and the OCT measurement is optical, this is not a given. This study therefore seeks a dataset of Helioscope measurements performed in eyes with cataract that can be used to develop the software algorithms of the Helioscope.
Eligibility Criteria
Inclusion criteria: * The presence of cataract in at least one eye. * Minimally 21 years of age. * Provided written informed consent. Exclusion criteria: * The inability to properly fixate on a fixation target for several seconds * The inability to provide informed consent.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07325162 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cataract and IOL Surgery. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07325162 currently recruiting?
Yes, NCT07325162 is actively recruiting participants. Contact the research team at m.petrik@cassini-technologies.com for enrollment information.
Where is the NCT07325162 trial being conducted?
This trial is being conducted at Hilton Head Island, United States.
Who is sponsoring the NCT07325162 clinical trial?
NCT07325162 is sponsored by Cassini Technologies. The trial plans to enroll 100 participants.